Business

Arno Therapeutics to Present at 11th Annual Noble Equity Conference

Arno Therapeutics to Present at 11th Annual Noble Equity Conference.

articleArno Therapeutics IncJanuary 8, 20154/company/arno-therapeutics/news/arno-therapeutics-to-present-at-11th-annual-noble-equity-conference
Arno Therapeutics to Present at 11th Annual Noble Equity Conference

About this update from Arno Therapeutics Inc

[{"type":"text","content":"\nFLEMINGTON, N.J., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics, today announced that Chief Operating Officer, Lawrence Kenyon, is scheduled to present at the Noble Financial Capital Markets' 11th Annual Equity Conference, being held January 18-21, 2015 at Club Med in Sandpiper Bay, FL.\n\n\tMr. Kenyon will present on Tuesday, January 20 at 4:00 p.m. EST to attending investors. During his presentation, Mr. Kenyon will discuss Arno's ongoing clinical development of lead candidate and personalized oncology therapy, onapristone, and recent milestones, including the first patient enrolled in the Phase II component of the Company's modified Phase I/II clinical study evaluating onapristone in women with progesterone receptor expressing tumors.\n\n\tDetails of the presentation are as follows:\n\n\t\n\t\t\n\t\t\t\n\t\t\t\tDate:\n\t\t\t\n\t\t\t\t \n\t\t\t\n\t\t\t\tTuesday, January 20, 2015\n\t\t\n\t\t\n\t\t\t\n\t\t\t\tTime:\n\t\t\t\n\t\t\t\t \n\t\t\t\n\t\t\t\t4:00 p.m. EST\n\t\t\n\t\t\n\t\t\t\n\t\t\t\tLocation:\n\t\t\t\n\t\t\t\t \n\t\t\t\n\t\t\t\tClub Med in Sandpiper Bay, Florida\n\t\t\n\t\t\n\t\t\t\n\t\t\t\tRoom:\n\t\t\t\n\t\t\t\t \n\t\t\t\n\t\t\t\tRoom 1\n\t\t\n\t\n\n\n\tAt the time of the Noble presentation, a live audio and high-definition video webcast of Arno Therapeutics presentation and a copy of the presentation materials will be available on the Company's web site www.arnothera.com, or through the Noble Financial websites: www.noblefcm.com, or www.nobleresearch.com/D2/2015.htm. Arno Therapeutics recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will also be archived on www.arnothera.com for 90 days following the event.\n\n\tAbout Arno Therapeutics\n\n\tArno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer and other life threatening diseases. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product can...

More updates from Arno Therapeutics Inc